SCHEMBL6880340

SCHEMBL6880340

COc1ccc(N(C)C2CCOCC2)cc1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ TUBB4A P04350 3/20 0.37
▸ TUBB P07437 3/20 0.37
▸ TUBA3C P0DPH7 3/20 0.37
▸ TUBA1B P68363 3/20 0.37
▸ TUBA4A P68366 3/20 0.37
▸ TUBB4B P68371 3/20 0.37
▸ TUBB3 Q13509 3/20 0.37
▸ TUBB2A Q13885 3/20 0.37
▸ TUBB8 Q3ZCM7 3/20 0.37
▸ TUBA3E Q6PEY2 3/20 0.37
▸ TUBA1A Q71U36 3/20 0.37
▸ TUBA1C Q9BQE3 3/20 0.37
▸ TUBB6 Q9BUF5 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2169887 0.82 NSD2 (0.42) ALDH1A1CYP3A4MEN1MAPTTHRB
SCHEMBL6870169 0.80 CSF1R (0.41) ALDH1A1CYP3A4MEN1MAPTTHRB
SCHEMBL6876218 0.79 KMT2A (0.46) ALDH1A1MEN1MAPTKMT2AGAA
SCHEMBL6874566 0.77 HTT (0.41) ALDH1A1MEN1MAPTTHRBKMT2A
SCHEMBL6874571 0.76 PDE4D (0.37) ALDH1A1MEN1KMT2AHTTNPC1
SCHEMBL4766178 0.73 TUBB4A (0.50) ALDH1A1CYP3A4MEN1MAPTTHRB
SCHEMBL10208072 0.72 ALDH1A1 (0.55) ALDH1A1CYP3A4MEN1MAPTTHRB
SCHEMBL30768329 0.70 APP (0.54) ALDH1A1CYP3A4MEN1MAPTTHRB
SCHEMBL2826258 0.70 NSD2 (0.42) ALDH1A1CYP3A4GAAEHMT2EHMT1
SCHEMBL12082444 0.70 ALDH1A1 (0.41) ALDH1A1MEN1MAPTKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713499-B2 ADENOSINE RECEPTOR AGONIST HOFFMAN-LA ROCHE INC. 2004-03-30 — — US disclosed
US-20030153566-A1 7-Amino-benzothiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153566-A1 7-Amino-benzothiazole derivatives ADORA1, ADORA2A, ADORA3 ALDH1A1 308/4885CYP3A4 954/4885MEN1 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback